Endoscopic Ultrasound (EUS) is one of the most advanced GI tools, essential for both diagnosis and minimally invasive procedures such as RFA, localized radiation therapy, and non-surgical drainage. However, its potential is limited by the years of expertise needed to perform these procedures safely and accurately. This makes EUS an ideal candidate for Human-AI collaboration, as it will enable more GI clinics to offer advanced treatments to more patients world-wide. Our patent-pending AI, developed at Clalit, excels at detecting pancreatic abnormalities and shows promising results in malignancy classification. Multiple clinical trial sites are already in place. Our founding team—experts in tech, AI, and clinical care—is driven to make advanced cancer treatments more accessible and effective for patients worldwide.